Concepedia

Oyekanmi Nash

ON

13

Publications

339

Citations

11

H-Index

2008

Active since

Affiliations

National Primary Health Care Development Agency(Current)

Afe Babalola University

African Field Epidemiology Network

London School of Hygiene & Tropical Medicine

University of Ibadan

Oyekanmi Nash is an author at National Primary Health Care Development Agency specializing in medicine, pharmacology, and cell biology.

ORCID

Top concepts

Publications per year

2008–2023

13

Publications

13

Flavonoid-rich extract of Chromolaena odorata modulate circulating GLP-1 in Wistar rats: computational evaluation of TGR5 involvement

Olaposi Idowu Omotuyi, Oyekanmi Nash, Olumide K. Inyang et al. · 3 Biotech · 2018 · 50 citations · Full text

, , +6

Atomistic simulation reveals structural mechanisms underlying <scp>D614G</scp> spike glycoprotein‐enhanced fitness in <scp>SARS‐COV</scp>‐2

Olaposi Idowu Omotuyi, Oyekanmi Nash, O. Basiru Ajiboye et al. · Journal of Computational Chemistry · 2020 · 49 citations · Full text

Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study

Opeyemi Soremekun, Ville Karhunen, Yiyan He et al. · EBioMedicine · 2022 · 41 citations · Full text

<scp><i>Aframomum melegueta</i></scp> secondary metabolites exhibit polypharmacology against <scp>SARS‐CoV</scp>‐2 drug targets: in vitro validation of furin inhibition

Olaposi Idowu Omotuyi, Oyekanmi Nash, Basiru Olaitan Ajiboye et al. · Phytotherapy Research · 2020 · 37 citations

SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody

Olaposi Idowu Omotuyi, Olujide O. Olubiyi, Oyekanmi Nash et al. · Computers in Biology and Medicine · 2022 · 36 citations · Full text

, , +6

Rows per page

1–5 of 13